Authors:
Never, L
Ehrnst, A
Belfrage, E
Blomberg, J
Christensson, B
Forsgren, M
Lidin-Janson, G
Lindgren, S
Ljung, R
Sonnerborg, A
Bohlin, AB
Citation: L. Never et al., Broad spectrum of time of detection, primary symptoms and disease progression in infants with HIV-1 infection, EUR J CL M, 20(3), 2001, pp. 159-166
Authors:
Ljung, R
Aronis-Vournas, S
Kurnik-Auberger, K
Van den Berg, M
Chambost, H
Claeyssens, S
Van Geet, C
Glomstein, A
Hann, I
Hill, F
Kobelt, R
Kreuz, W
Mancuso, G
Muntean, W
Petrini, P
Rosado, L
Scheibel, E
Siimes, M
Smith, O
Tusell, J
Citation: R. Ljung et al., Treatment of children with haemophilia in Europe: a survey of 20 centres in 16 countries, HAEMOPHILIA, 6(6), 2000, pp. 619-624
Authors:
Carlborg, E
Astermark, J
Lethagen, S
Ljung, R
Berntorp, E
Citation: E. Carlborg et al., The Malmo model for immune tolerance induction: impact of previous treatment on outcome, HAEMOPHILIA, 6(6), 2000, pp. 639-642
Citation: U. Tedgard et al., Long-term psychological effects of carrier testing and prenatal diagnosis of haemophilia: Comparison with a control group, PRENAT DIAG, 19(5), 1999, pp. 411-417
Citation: U. Tedgard et al., How do carriers of hemophilia and their spouses experience prenatal diagnosis by chorionic villus sampling?, CLIN GENET, 55(1), 1999, pp. 26-33
Authors:
Astermark, J
Petrini, P
Tengborn, L
Schulman, S
Ljung, R
Berntorp, E
Citation: J. Astermark et al., Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized, BR J HAEM, 105(4), 1999, pp. 1109-1113
Authors:
Tengborn, L
Hansson, S
Fasth, A
Lubeck, PO
Berg, A
Ljung, R
Citation: L. Tengborn et al., Anaphylactoid reactions and nephrotic syndrome - a considerable risk during factor IX treatment in patients with haemophilia B and inhibitors: a report on the outcome in two brothers, HAEMOPHILIA, 4(6), 1998, pp. 854-859